National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
ELEPHAS-04
Recruiting
324 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
(TRUS)
Recruiting
17 enrolled
NeCTuR
Recruiting
750 enrolled
Detecting HPV DNA in Anal and Cervical Cancers
Recruiting
20 enrolled
PROVE
Recruiting
1,300 enrolled
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
Recruiting
50 enrolled
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
Recruiting
18 enrolled
THRIVE
Recruiting
1,000 enrolled
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Recruiting
300 enrolled
SCOUT-1
Recruiting
750 enrolled
HERO
Recruiting
1,000 enrolled
Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer
Recruiting
270 enrolled
IREN
Recruiting
500 enrolled
DP-04
Recruiting
100 enrolled
PARIB-OLD-PRO²
Recruiting
50 enrolled
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
Recruiting
1,800 enrolled
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
Recruiting
70 enrolled
DUOLife
Recruiting
150 enrolled
Retro-COSMOS
Recruiting
350 enrolled
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Recruiting
60 enrolled
IMPrOVE
Recruiting
300 enrolled
BASECAMP-1
Recruiting
200 enrolled
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Recruiting
480 enrolled
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
Recruiting
55 enrolled
ESG-ENDO
Recruiting
74 enrolled
MUSA3
Recruiting
1,000 enrolled
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Recruiting
120 enrolled
SJFAMILY
Recruiting
1,500 enrolled
AGBR-FERN-Gyn
Recruiting
1,000 enrolled
Healthy Volunteers Study
Recruiting
50 enrolled
STIRR
Recruiting
110 enrolled
NCG-Compliance
Recruiting
618 enrolled
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
Recruiting
600 enrolled
OLIVIA
Recruiting
250 enrolled
ATICC
Recruiting
50 enrolled
DOSTCONICG
Recruiting
30 enrolled
SMARAGD
Recruiting
1,975 enrolled
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Recruiting
50 enrolled
The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
Recruiting
120 enrolled
iCaRe2
Recruiting
999,999 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
Recruiting
45 enrolled
ECHO
Recruiting
3,110 enrolled